๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Anti-HER2 monoclonal antibodies

โœ Scribed by J. Baselga

Book ID
117658770
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
177 KB
Volume
37
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Bispecific monoclonal antibody therapy (
Bispecific monoclonal antibody therapy (anti HER-2/neu ร— anti CD 64) for human breast cancers that overexpress HER-2/neu
โœ Frank H. Valone; Peter A. Kaufman; Michael W. Fanger; Paul M. Guyre; Clark Sprin ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 184 KB

One of the most critical issues regarding management of early breast cancer is the proper detection and correct estimation of its malignant potential. In recent years, primarily through mammography, the frequency of ductal carcinoma in situ (DCIS) in malignant breast biopsies has increased several f

Disialoganglioside GD2 anti-idiotypic mo
Disialoganglioside GD2 anti-idiotypic monoclonal antibodies
โœ Nai-Kong V. Cheung; Adela Canete; Irene Y. Cheung; Jian-Nan Ye; Chongyuan Liu ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 788 KB

Disialoganglioside GD2 is widely expressed among neuroblastomas, melanomas, small-cell lung carcinoma, sarcomas and brain tumors. Immunity directed against this antigen may have anti-tumor utility. Since GDz is poorly immunogenic, antiidiotypic antibodies may serve as alternative tumor vaccines. Mon